# Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

> **NCT03015909** · PHASE4 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 116 (actual)

## Conditions studied

- Short Stature, Idiopathic
- Infant, Small for Gestational Age
- Growth Hormone Deficiency
- Chronic Renal Failure
- Turner Syndrome

## Interventions

- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT03015909
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-11
- **Primary completion:** 2017-12-21
- **Final completion:** 2017-12-21
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2019-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015909, "Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03015909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*